Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Manganese and Melatonin

supplement:

Manganese

supplement:

Melatonin

Research Papers that Mention the Interaction

In addition, melatonin pretreatment attenuated Mn and/or LPS-induced degradation of IκB-α, nuclear translocation of nuclear factor-κB (NF-κB) and its activation, and the expressions of inducible nitric oxide synthase (iNOS) and nitric oxide (NO) in BV2 microglial cells.
Melatonin (10 μM) inhibited Mn (100 μM) and/or LPS (0.5 μg/ml)-induced phagocytotic activity of activated BV2 microglia.
Melatonin effectively suppressed the upregulation of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) at both mRNA and protein levels in Mn and/or LPS-stimulated BV2 microglia.
Neurochemical Research  •  2016  |  View Paper
Melatonin partially prevented the loss of MN and alleviated the inflammation and oxidative stress induced by DNBS.
These results indicate that melatonin protects MN from damage by reducing inflammation and oxidative stress, effects that are partly mediated by the Nrf2–ARE pathway.
Fundamental & clinical pharmacology  •  2016  |  View Paper
While melatonin treatment induced the expression of Mn SOD mRNA and a continual increase of Mn SOD activity as well as the activity and mRNA expression of Cu–Zn SOD at 12 weeks.
Neurochemical Research  •  2012  |  View Paper
This effect of Mn appeared to be mediated by oxidative stress, as it was reversed by antioxidants ( melatonin and PBN) and by increasing glutathione levels, while it was potentiated by glutathione depletion in astrocytes.
Toxicology and applied pharmacology  •  2009  |  View Paper
In the animals treated with MEL + Mn a higher reduction in MDA levels was observed.
These results suggest that MEL modulates the effect of Mn on SMA and brain lipid peroxidation.
Neurochemical Research  •  2004  |  View Paper
Our results demonstrate that melatonin administration decreases the percentage of damaged cells, porphyrin synthesis, and aminolevulinate synthase (ALA‐S) mRNA levels and increases the mRNA levels for manganese superoxide‐dismutase and copper‐zinc superoxide dismutase.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology  •  1996  |  View Paper